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ABSTRACT 
 
The present study aims to evaluate the cytotoxicity and antitumor activity of the ethanolic extract of leaves 
of Syzygium aqueum (EESA) on K562 tumor cell line (chronic myeloid leukemia) and transplantable tumor 
Dalton’s ascites lymphoma (DAL). In-vitro cytotoxicity on K562 tumor cell line was evaluated using micro-
culture tetrazolium (MTT) assay. In-vivo antitumor activity was studied on DAL tumor bearing mice. Activity 
was assessed by monitoring the mean survival time, tumor cell count, percentage increase in body weight 
and effect on haematological parameters like red blood cell (RBC) count, haemoglobin content (Hb), white 
blood cell (WBC) count, Differential cell (DC) count. Histopathological studies were also evaluated during 
this study. EESA exhibit potent in-vitro cytotoxicity activity against K562 tumor cell line. The result also 
showed an increased life span and decreased tumor cell count in S.aqueum treated animals. The 
hematological studies revealed that the Hb count decreased in DAL bearing mice, whereas S.aqueum treated 
mice showed an increase in the Hb or near to normal levels and other hematological parameters such as 
RBC, WBC was also significantly reduced. Histopathalogical studies evaluated the destruction of tumor cells 
by showing cell wall destruction, membrane blebbing, degradation, vacuolated cytoplasm. The results 
suggested that the EESA exhibited cytotoxicity in dose dependent and it showed significant antitumor 
activity on DAL bearing mice. 
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INTRODUCTION 
Herbal medicine has been used as a major treatment 
for cancer in various countries in the Middle East and 
Europe a long time ago. Recent reports released by 
the World Health Organization (WHO) showed that 
although many advanced countries have considered 
traditional herbal treatment as an official treatment 
for cancer, only 5–15% of these herbs have been 
investigated to detect their bioactive compounds, i.e., 
anticancer compounds Researchers mentioned that 
herbal-based medicines are found to be one of the 
best choices for treating and/or preventing the 
incidence of cancer. 
Cancer is a disease where an uncontrolled 
proliferation of cells takes place. Even though many 
number of anticancer drugs are available in the 
market, the use of chemotherapy is restricted 
because of their adverse reaction. Moreover, almost 
all anticancer drugs follow first-order kinetics, and 
chances of development of resistance were more. 
Anticancer drugs obtained from natural origin (i.e.) 
like Vinblastine, Vincristine, Taxol, Podophyllum 
were comparatively safer than other cytotoxic drugs. 
Terpenoids such as xanthorhizole, Flavonoids such as 
myricetin, genistein, biochanin-A, Biocolein, etc. were 
reported for anticancer activity against many 
transplantable tumors. 
Myricetin, a member of the flavonol class of 
flavonoids has an anticancer effect against several 
types of cancer [1] like prostate cancer, hepatocellular 
carcinoma, gastric cancer, and human squamous cell 
carcinoma [2,3,4,5]. Myricetin may also increase the 
chemotherapeutic potential of certain anticancer 
drugs by sensitizing the target cancer cells to 
chemotherapy [6,7]. 
Biochanin A, an isoflavone, is known to exert an 
anticancer effect on various cancer types [8,9,10]. 
Although not fully understood, there is some 
evidence that isoflavones target tyrosine 
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phosphorylase, topoisomerase, and drug 
transporters. Bio-A blocked the proliferation of 
glioblastoma, breast, pancreatic, and oral squamous 
cancer cells. Bio-A present in the diet may suppress 
tumor growth and be used in the prevention and 
combination chemotherapy that would lead to a 
better outcome of cancer treatment [11]. 
Genistein acts as a chemotherapeutic agent against 
different types of cancer, mainly by altering 
apoptosis, the cell cycle, angiogenesis, and inhibiting 
metastasis [12]. Genistein has been shown to suppress 
the growth of several cancers through modulation of 
various pathways [13] and they exhibited cytotoxicity 
against various cancer cell lines [14]. 
Xanthorrhizol has been known to curb the 
proliferation of liver cancer by inducing apoptosis 
through bax control and p53 in a cell [15]. 
Furthermore, XNT has also been known to possess 
antiproliferative characteristics against breast cancer 
MCF- 7 [16,17]. 
Syzygium aqueum belonging to the family Myrtaceae 
is a medicinal plant widely found in tropical regions 
such as Malaysia and Indonesia [18]. Plant Syzygium 
aqueum has been reported to possess various 
phytoconstituents such as flavonoids [19], tannins, and 
terpenoids [20]. Based on the main components of 
Syzygium aqueum, we assume/presume that 
Syzygium aqueum extract may have anticancer 
activities against some cancer cell lines in-vitro and 
in-vivo transplantable tumor model. To confirm this 
presume we planned to evaluate the anti-tumor 
activity of ethanolic extract of Syzygium aqueum 
leaves against mice model of Dalton’s ascites 
lymphoma. 
MATERIALS AND METHODS 
Collection and authentication of plant part 
Syzygium aqueum leaves were collected from Mahe, 
Pondicherry in the month of November 2017. The 
plant was authenticated by the Botanist, French 
Institute, Pondicherry and the voucher specimen was 
submitted in the department of Pharmacology, MTPG 
& RIHS for future reference (HIFP 27058). 
Extraction 
Syzygium aqueum leaves (50gm) were shade dried, 
pulverized, packed in Soxhlet extractor and extracted 
with ethanol (500ml) by continuous hot percolation 
using Soxhlet apparatus. The ethanol was removed 
from the extract by Distillation (solvent recovery) 
method. The extract was dissolved in Phosphate 
Buffer Saline and used for experiment.  
Tumor cells 
Dalton’s ascites lymphoma (DAL) transplantable 
tumor was maintained in our laboratory through the 
courtesy of Amala Cancer Research Centre, Thrissur. 
All the animals except saline control were inoculated 
with 0.1ml of cell suspension of DAL (1×106cells/ml). 
In-vitro cytotoxicity activity (MTT assay) 
K562 tumor cell line (chronic myeloid leukemia) 
were procured from NCCS, Pune and maintained on a 
culture in department of Biochemistry, Pondicherry 
University, Puducherry. Cells (1 × 105/well) were 
plated in 1ml of medium/well in 24-well plates. After 
48 hours incubation the cell reaches the confluence. 
Then, cells were incubated in the presence of various 
concentrations of the samples in 0.1% DMSO for 48h 
at 37°C. After removal of the sample solution and 
washing with phosphate-buffered saline (PH 7.4), 
200µl/well (5mg/ml) of 0.5% 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-tetrazolium bromide cells 
(MTT) phosphate- buffered saline solution was 
added. After 4h incubation, 0.04M HCl/ isopropanol 
were added. Viable cells were determined by the 
absorbance at 570nm. Measurements were 
performed and the concentration required for a 50% 
inhibition of viability (IC50) was determined 
graphically [21]. 
Percentage of cell viability was determined as 
(
Avg.OD of treated cells
Avg.OD of control cells
) 𝑥 100[22]  
In-vivo anticancer activity 
Animals 
Healthy Swiss Albino Mice of 4-6 weeks old weighing 
between 18-25gms were procured from Biogen 
Laboratory animal facility, Bangalore. They were 
housed in polypropylene cages and maintained under 
standard conditions of 25±2ºC with 12h dark/light 
cycle. The animals were fed with standard animal 
pellet diet and water ad libitum. The experimental 





The acute and subchronic toxicity effects of the 
Syzygium aqueum leaves are evaluated and the data 
clearly shows there were no acute or subchronic 
toxicity observed [23]. 
All the animals except saline control were inoculated 
with 0.1ml of cell suspension of DAL (1×106cells/ml). 
Later these animals were grouped as follows each 
consisting of 10 animals: 
Group I: Normal saline control; Group II: Tumor 
bearing mice; Group III: Ethanolic extract of Syzygium 
aqueum (200mg/kg); Group IV: Ethanolic extract of 
Syzygium aqueum (400mg/kg); Group V: -5-
Fluorouracil (20mg/kg) 
After 24hrs of tumor inoculation, the treatment with 
Syzygium aqueum extract was started and continued 
for 9 days [24]. Comparison was made between groups 
of mice on the fourteenth day after inoculation.  
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(i) Effect of ethanolic extract of Syzygium 
aqueum on survival time 
Animals were inoculated with 1×106DAL cells 
per mouse on day 0 and treatment was started 
with Syzygium aqueum, 24 hr after inoculation, 
at a dose of 200 mg/kg and 400 mg/kg/ day i.p. 
The control group was treated with the same 
volume of phosphate buffer solution. All the 
treatments were continued for 9 days. The mean 
survival time (MST) of each group consisting of 
10 mice was noted and the antitumor efficacy of 
Syzygium aqueum was compared with that of 5- 
fluorouracil (5Fu) (20mg/kg, i.p). The MST was 
calculated using the following formula [25] 
𝑀𝑆𝑇 =   (1𝑠𝑡 𝑑𝑒𝑎𝑡ℎ + 𝐿𝑎𝑠𝑡 𝑑𝑒𝑎𝑡ℎ)/2   
(ii) Percentage increase in lifespan (%ILS) 
From the recorded MST, % ILS was calculated 
using the following formula %ILS = (MST of 
respective group – MST of tumor bearing group 
Previous body weight) ×100 
(iii) Effect of ethanolic extract of Syzygium 
aqueum on haematological parameters 
To determine the effect of Syzygium aqueum on 
the haematological parameters of DAL bearing 
mice comparison was made amongst five groups 
(n=10) of mice on the 14th day after 
transplantation. At the end of the experimental 
period, blood was collected from retro-orbital 
pluxes, and the red blood cell (RBC) count, 
haemoglobin content (Hb), and white blood cell 
(WBC) count was determined [26,27]. Differential 
cell (DC) count was carried out [25]. 
(iv) Effect of ethanolic extract of Syzygium 
aqueum on tumor cell count 
The ascitic fluid was taken in a hematocrit 
(micro) tube and diluted 1000 times. Then a 
drop of the diluted cell suspension was placed 
on the Neubauer counting chamber and the cells 
were counted [28,29]. 
(v) Effect of ethanolic extract of Syzygium 
aqueum on Body weight, percentage increase 
in body weight 
All the mice were weighed from the day of 
transplantation till the end of the treatment 
period. The Average increase in body weight 
was determined. 
(vi) Histopathological studies 
The DAL tumor cells from the ascitic fluid of 
different treatment groups were stained with 
hematoxylin and eosin stain and studied 
histopathologically 
(vii) Statistical analysis 
Statistical analysis was carried out using Graph 
pad prism 7.0 (Graph pad software). All results 
are expressed as mean± S.E.M. Groups of data 
were compared with the analysis of variance 
(ANOVA) followed by Dunnett’s t-test to identify 
significance among groups. Values were 
considered statistically significant when p < 
0.05. 
RESULTS 
(i) In-vitro cytotoxicity (MTT assay) 
The effect of ethanolic extract of leaves of 
S.aqueum on K562 cell line was evaluated 
through micro-culture tetrazolium assay (MTT). 
In these studies, the cells were treated with 
multiple concentrations of ethanolic extract of S. 
aqueum (100 – 500 µg/ml). The percentage 
cytotoxicity increased along with concentration. 
The ethanolic extract of S.aqueum at a 
concentration of 500µg/ml produced 51% of 
cytotoxicity against K562 cell line. It was 
observed that the cytotoxicity is dose-
dependent. 
Table 1: Effect of ethanolic extract of Syzygium 
aqueum on K562 cell line 
S.No 
Concentration of  


















*Experiments were carried out only once 
In-vivo antitumor activity using DAL cell lines 
(i) Effect of ethanolic extract of Syzygium 
aqueum on survival time 
The effect of ethanolic extract of S.aqueum on the 
survival of tumor-bearing mice showed MST for 
the tumor control group to be 15 days, while it 
was 23 ± 0.83 days for S.aqueum extract  
(200mg/kg  i.p),  22  ±  0.70  days  for  400mg/kg  
and  standard 5-fluorouracil (20mg/kg i.p) 
found to be 23.5 ± 0.32 days. The increase in the 
lifespan of tumor- bearing mice treated with 
Syzygium aqueum and 5-Fu was found to be 
46.6%, 56.6% and 53% respectively as 
compared to the control group (Table 2). 
(ii) Effect of ethanolic extract of Syzygium 
aqueum on haematological parameters 
Haematological parameters of tumour bearing 
mice on the 15th day showed significant changes 
when compared with the normal mice (Table 3) 
and the results confirmed the rise in WBC in DAL 
induced animals, might be a defensive 
mechanism against cancer cells. Significant 
reduction in the raised WBC count was noticed 
after treatment with S.aqueum extract while the 
haemoglobin content of red blood cells count 
decrease  
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(iii) Determination of tumor cell count 
The effect of S.aqueum was examined on the 
peritoneal exudate of DAL tumor mice (Table 4). 
Normally each mouse contain about 5×106/ml 
intraperitoneal cells [30], whereas DAL tumor 
bearing mice exhibited 25×106/ml. Upon 
treatment with S.aqueum 200 and 400mg/kg, 
these cell counts has been reduced to 17.1 and 
11×106cells/ml respectively 
(iv) Effect of ethanolic extract of Syzygium 
aqueum on Body weight, Percentage increase 
in body weight 
Intraperitoneal inoculation of DAL cells 
produced a marked increase in the cancer cell 
count and it is represented by gain in body 
weight. The increase in body weight was may be 
due to accumulation of peritoneal fluid as 
suggested by an abnormal enlargement of 
peritoneal cavity in tumour induced mice. The 
decrease in the body weight & %IBW observed 
in the S.aqueum treated group indicates that it 
possess significant inhibitory effect on the 
tumour cell proliferation. The results were 
shown in (Table 5). 
(v) Histopathological Studies 
The DAL tumor cells from the ascetic fluid of 
different treatment groups were stained with 
hematoxylin and eosin stain. They showed 
marked cytological changes when compared to 
Table 2: Effect of ethanolic extract of syzygium aqueum leaves treatment on survival of tumor bearing mice 
S.No Treatment Mean Survival Time (Mst) Increase in Life Span (%) 
1. Normal control - - 
2. Tumor control 15 ± 1.1 - 
3. EESA (200mg/kg ip) 22 ± 0.70* 46.6 
4. 
 
EESA (400mg/kg ip) 23 ± 0.83* >53 
5. 5- Fu (20mg/kg ip) 23.5 ± 0.32* >56.6 
*Values are expressed as mean ± SEM. Number of animals used in each group = 10. Statistically, values are presented as follows: * P < 
0.01 significant differences compared to tumor controls. Data were analyzed by One way ANOVA followed by Dunnett’s t-test. 















1. Normal control 14.2±0.45* 10.86±0.49* 8.8±0.29* 74±0.8* 25±0.84* 2 ± 0.11* 










2.9±0.14* 1.71±0.04* 13.12±0.89* 82±0.70* 16.4±0.73* 1.6 ± 0.10* 
5. 5-Fu 20mg/kg 2.0±0.14* 2.56±0.17* 9.06±0.02* 72.3±0.44* 25.4±0.96* 2.3 ± 0.17* 
   *p<0.01 vs. DLA control. Number of animals = 10 in each group. Statistically, values are presented as follows: * P < 0.01 significant dif-
ferences compared to tumor controls. Data were analyzed by One way ANOVA followed by Dunnett’s t-test. 
Table 4: Effect of ethanolic extract of Syzygium aqueum treatment on the tumor volume and WBC cell 
count 
S.no Treatment Tumor Volume (ml) WBC (106/ml) 
1. Normal control 10 ± 0.64 5 ± 0.13 
2. Tumor control 11.5 ± 0.57* 25 ± 1.15 
3. EESA 200mg/kg i.p 12 ± 0.44* 17.1 ± 0.34 
4. EESA 400mg/kg i.p 6.5 ± 0.41* 11 ± 0.90 
5. 5- FU 20mg/kg - - 
Values are expressed as mean ± SEM. Number of animals used in each group = 10. Statistically, values are presented as follows: * P < 0.01 
significant differences compared to tumor controls. Data were analyzed by One way ANOVA followed by Dunnett’s t-test. 
Table 5: Effect of ethanolic extract of Syzygium aqueum treatment on body weight, percentage increase in 
body weight 
Treatment 
Body Weight (gm) Percentage Increase in Body Weight (%) 
1st Day 7th Day 14th Day 7th Day 14th Day 
Normal control 19.7 ± 0.3 21 ± 0.3 22 ± 0.8 6.59 4.7 
Tumor control 19.3± 1.9* 23.14± 3.4* 34.1± 6.7* 19.8 47 
EESA 200mg/kg i.p 18.49± 1.8* 21.26± 1.9* 23.3± 2.2* 14.9 9.5 
EESA 400mg/kg i.p 18.35± 1.6* 21.08± 2* 24.25± 2.3* 14.8 15 
5- Fu 20mg/kg i.p 19.3± 3.4* 21.5± 1.3* 24 ± 2.3* 11 16 
Values are expressed as mean ± SEM. Number of animals used in each group = 10. Statistically, values are presented as follows: * P < 0.01 
significant differences compared to tumor controls. Data were analyzed by One way ANOVA followed by Dunnett’s t-test. 
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tumor control cells. (Figure 1; Figure 2; Figure 
3; Figure 4; Figure 5; Figure 6; Figure 7). 
CONCLUSION 
The present study was carried out to evaluate the 
antitumor effect of S.aqueum in DAL-bearing mice. 
The reliable criteria for judging the value of any 
anticancer drugs were the prolongation of the life 
span of animals, reduction in tumor volume and 
reduction of WBC from blood [31, 32, 29]. Our results 
show an increase in lifespan accompanied by a 
reduction in WBC count in S.aqueum treated mice. It 
had significant effect in increasing the life span of 
ascitic tumor bearing animals. The S.aqueum treated 
animals at the doses of 200 and 400 mg/kg 
significantly inhibited and brought back the 
hematological parameters to more or less normal 
levels. This extract also reduced the tumor volume. 
To evaluate whether S.aqueum treatment indirectly 
inhibited the tumor cell growth, the effect of 
S.aqueum was examined on the peritoneal exudate of 
DAL tumor mice. Normally each mouse contain about 
5×106 intraperitoneal cells [30], whereas DAL tumor 
bearing mice exhibited 25×106/ml. Upon treatment 
with S.aqueum 200 and 400mg/kg, these cell counts 
has been reduced to 17.1 and 11×106 cells/ml 
respectively. All these data point to the possibility of 
developing an ethanolic extract of S.aqueum as a 
novel, potential agent in the area of cancer 
chemotherapy. The phytochemical studies indicated 
the presence of flavonoids [19] and terpenoids [20] in 
S.aqueum extract. Flavonoids have been shown to 
possess antimutagenic and anti-malignant effects 
[33,34]. According to the previous reports, S.aqueum 
possess antioxidant activity [20]. Thus, anti-tumor 
effects may be due to flavonoids as well as its 
antioxidant activity. 
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